Deals Rumor Mill: Pfizer, Cosco Group, Towers Watson

By Benjamin Horney (November 19, 2015, 6:05 PM EST) -- Pfizer Inc. is closing in on a deal to buy Allergan PLC, the New York Times reported Thursday, and the transaction could see the pharmaceutical giant pay up to $150 billion for the Irish drugmaker. According to the report, a deal could value Allergan at up to $380 per share, and such a transaction would be the largest so far this year. The two companies confirmed in late October that they were in talks concerning a potential deal, though at that time they described it as "preliminary friendly discussions." Bringing together Allergan and Pfizer would create a pharmaceutical behemoth with a combined market capitalization of nearly $340 billion....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!